Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PathAI
MedTech
Roche shells out up to $1B for PathAI to boost AI diagnostics
Roche will pay more than $1 billion to acquire digital pathology specialist Path AI in a move to bolster its use of artificial intelligence.
Joseph Keenan
May 7, 2026 9:30am
Clario and PathAI partner up to build GI clinical trial workflow
Oct 16, 2024 3:00pm
Quest Diagnostics carves out PathAI's digital pathology lab
May 1, 2024 10:30am
Merck poaches marketing chief from Biogen—Chutes & Ladders
Jun 24, 2022 9:30am
PathAI co-founder joins Iterative Scopes as CTO
Jun 21, 2022 12:48pm
GSK, PathAI link up for cancer, NASH drug development
Apr 5, 2022 8:00am
